Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1990 January; 85(1): 135–138.
PMCID: PMC296397

Carrier detection in xeroderma pigmentosum.


We were able to detect clinically normal carriers of xeroderma pigmentosum (XP) genes with coded samples of either peripheral blood lymphocytes or skin fibroblasts, using a cytogenetic assay shown previously to detect individuals with cancer-prone genetic disorders. Metaphase cells of phytohemagglutinin-stimulated T-lymphocytes from eight individuals who are obligate heterozygotes for XP were compared with those from nine normal controls at 1.3, 2.3, and 3.3 h after x-irradiation (58 R) during the G2 phase of the cell cycle. Lymphocytes from the XP heterozygotes had twofold higher frequencies of chromatid breaks or chromatid gaps than normal (P less than 10(-5)) when fixed at 2.3 or 3.3 h after irradiation. Lymphocytes from six XP homozygotes had frequencies of breaks and gaps threefold higher than normal. Skin fibroblasts from an additional obligate XP heterozygote, when fixed approximately 2 h after x-irradiation (68 R), had a twofold higher frequency of chromatid breaks and a fourfold higher frequency of gaps than fibroblasts from a normal control. This frequency of aberrations in cells from the XP heterozygote was approximately half that observed in the XP homozygote. The elevated frequencies of chromatid breaks and gaps after G2 phase x-irradiation may provide the basis of a test for identifying carriers of the XP gene(s) within known XP families.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (821K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol. 1985 Jan-Mar;3(1):33–69. [PubMed]
  • Parshad R, Sanford KK, Jones GM, Tarone RE. G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet. 1985 Jan 1;14(1-2):163–168. [PubMed]
  • Shiloh Y, Parshad R, Sanford KK, Jones GM. Carrier detection in ataxia-telangiectasia. Lancet. 1986 Mar 22;1(8482):689–690. [PubMed]
  • Parshad R, Sanford KK, Jones GM. Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5612–5616. [PubMed]
  • Parshad R, Sanford KK, Jones GM. Chromosomal radiosensitivity during the G2 cell-cycle period of skin fibroblasts from individuals with familial cancer. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5400–5403. [PubMed]
  • Parshad R, Gantt R, Sanford KK, Jones GM. Chromosomal radiosensitivity of human tumor cells during the G2 cell cycle period. Cancer Res. 1984 Dec;44(12 Pt 1):5577–5582. [PubMed]
  • Sanford KK, Parshad R, Gantt R, Tarone RE, Jones GM, Price FM. Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer. Int J Radiat Biol. 1989 Jun;55(6):963–981. [PubMed]
  • MOORHEAD PS, NOWELL PC, MELLMAN WJ, BATTIPS DM, HUNGERFORD DA. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res. 1960 Sep;20:613–616. [PubMed]
  • Ritter MA, Williams JR. Fluorescent-light-induced lethality and DNA repair in normal and xeroderma pigmentosum fibroblasts. Biochim Biophys Acta. 1981 Aug 27;655(1):18–25. [PubMed]
  • Goth-Goldstein R. Repair of DNA damaged by alkylating carcinogens is defective in xeroderma pigmentosum-derived fibroblasts. Nature. 1977 May 5;267(5606):81–82. [PubMed]
  • Setlow RB, Faulcon FM, Regan JD. Defective repair of gamma-ray induced DNA damage in xeroderma pigmentosum cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1976 Feb;29(2):125–136. [PubMed]
  • Chan GL, Little JB. Cross-sensitivity of certain xeroderma pigmentosum and Cockayne syndrome fibroblast strains to both ionizing radiation and ultraviolet light. Mol Gen Genet. 1981;181(4):562–563. [PubMed]
  • Swift M, Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst. 1979 Jun;62(6):1415–1421. [PubMed]
  • Welshimer K, Swift M. Congenital malformations and developmental disabilities in ataxia-telangiectasia, Fanconi anemia, and xeroderma pigmentosum families. Am J Hum Genet. 1982 Sep;34(5):781–793. [PubMed]
  • Cleaver JE. Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light. J Invest Dermatol. 1972 Mar;58(3):124–128. [PubMed]
  • Cleaver JE, Bootsma D. Xeroderma pigmentosum: biochemical and genetic characteristics. Annu Rev Genet. 1975;9:19–38. [PubMed]
  • Kleijer WJ, de Weerd-Kastelein EA, Sluyter ML, Keijzer W, de Wit J, Bootsma D. UV-induced DNA repair synthesis in cells of patients with different forms of xeroderma pigmentosum and of heterozygotes. Mutat Res. 1973 Dec;20(3):417–428. [PubMed]
  • Bootsma D, Mulder MP, Cohen JA, Pot F. Different inherited levels of DNA repair replication in xeroderma pigmentosum cell strains after exposure to ultraviolet irradiation. Mutat Res. 1970 May;9(5):507–516. [PubMed]
  • Pawsey SA, Magnus IA, Ramsay CA, Benson PF, Giannelli F. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum. Q J Med. 1979 Apr;48(190):179–210. [PubMed]
  • Squires S, Johnson RT. Kinetic analysis of UV-induced incision discriminates between fibroblasts from different xeroderma pigmentosum complementation groups, XPA heterozygotes and normal individuals. Mutat Res. 1988 Mar;193(2):181–192. [PubMed]
  • Giannelli F, Pawsey SA. DNA repair synthesis in human heterokaryons. II. A test for heterozygosity in xeroderma pigmentosum and some insight into the structure of the defective enzyme. J Cell Sci. 1974 Jun;15(1):163–176. [PubMed]
  • Day RS., 3rd Studies on repair of adenovirus 2 by human fibroblasts using normal, xeroderma pigmentosum, and xeroderma pigmentosum heterozygous strains. Cancer Res. 1974 Aug;34(8):1965–1970. [PubMed]
  • Rainbow AJ. Reduced capacity to repair irradiated adenovirus in fibroblasts from xeroderma pigmentosum heterozygotes. Cancer Res. 1980 Nov;40(11):3945–3949. [PubMed]
  • Selsky CA, Greer S. Host-cell reactivation of UV-irradiated and chemically-treated herpes simplex virus-1 by xeroderma pigmentosum, XP heterozygotes and normal skin fibroblasts. Mutat Res. 1978 Jun;50(3):395–405. [PubMed]
  • Miskin R, Ben-Ishai R. Induction of plasminogen activator by UV light in normal and xeroderma pigmentosum fibroblasts. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6236–6240. [PubMed]
  • McCurry LS, Jacobson MK. Poly(ADP-ribose) synthesis following DNA damage in cells heterozygous or homozygous for the xeroderma pigmentosum genotype. J Biol Chem. 1981 Jan 25;256(2):551–553. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation